Zobrazeno 1 - 10
of 3 364
pro vyhledávání: '"therapy related"'
Autor:
Xander Jacquemyn, Bhargava K. Chinni, Benjamin T. Barnes, Sruti Rao, Shelby Kutty, Cedric Manlhiot
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Background Anthracyclines are essential in pediatric cancer treatment, but patients are at risk cancer therapy-related cardiac dysfunction (CTRCD). Standardized definitions by the International Cardio-Oncology Society (IC-OS) aim to enhance
Externí odkaz:
https://doaj.org/article/5bef8372931f4332846735c7f9980dbd
Autor:
Anna Borowiec, Patrycja Ozdowska, Magdalena Rosinska, Agnieszka Maria Zebrowska, Agnieszka Jagiello-Gruszfeld, Sławomir Jasek, Joanna Waniewska, Beata Kotowicz, Hanna Kosela-Paterczyk, Elzbieta Lampka, Katarzyna Pogoda, Andrzej Cieszanowski, Zbigniew Nowecki, Jan Walewski
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Background The presence and burden of coronary artery calcium (CAC) is a strong predictor of cardiovascular events. Current guidelines of the European Society of Cardiology (ESC) for cardio-oncology do not recommend the use of the CAC score
Externí odkaz:
https://doaj.org/article/33619deb81f04d9696be173be58f4cfa
Autor:
Michelle Bloom, Jose A. Alvarez-Cardona, Sarju Ganatra, Ana Barac, Iskra Pusic, Daniel Lenihan, Susan Dent
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-6 (2024)
Abstract Heart failure (HF) in patients with cancer is associated with high morbidity and mortality. The success of cancer therapy has resulted in an exponential rise in the population of cancer survivors, however cardiovascular disease (CVD) is now
Externí odkaz:
https://doaj.org/article/f3a584b5941c46819cccf9e938764430
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 4089-4116 (2024)
Feiyu Gao,* Tao Xu,* Fangnan Zang, Yuanyuan Luo, Defeng Pan Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221004, People’s Republic of China*These authors contributed equally to this wo
Externí odkaz:
https://doaj.org/article/43e1626fe91043b9a55341759e52c04b
Autor:
Dan Imai, Emi Ushigome, Ryosuke Sakai, Noriyuki Kitagawa, Masahide Hamaguchi, Masahiro Yamazaki, Michiaki Fukui
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 8, Pp 1042-1046 (2024)
Abstract Aims/Introduction We aimed to investigate the association between glycemic variability and quality of life (QOL) in patients with diabetes, which has not been studied previously. Materials and Methods Patients who were undergoing treatment a
Externí odkaz:
https://doaj.org/article/d1886cd1e7614f6386264fdb025ddba0
Autor:
Kang Huang, Denggao Huang, Qiang Li, Jiangting Zeng, Ting Qin, Jianghua Zhong, Zanrui Zhong, Shijuan Lu
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Due to the cancer therapy-related cardiovascular toxicity, heart failure following cancer therapy has a significant mortality rate. Gene-targeted therapy promotes the re-entry of existing cardiomyocytes into the cell cycle to achieve myocard
Externí odkaz:
https://doaj.org/article/07028aba90c84657b7383f948607b240
Autor:
Libo Zhang, Meijuan Huang
Publikováno v:
Heliyon, Vol 10, Iss 17, Pp e37040- (2024)
Case summary: A 45-year-old man presented with a 4.0cm × 4.0cm mass in right lower lobe and a right lower lobectomy was performed. The pathological diagnosis from the right lower lobe mass was adenocarcinoma with an EGFR mutation in exon 21 (L858R).
Externí odkaz:
https://doaj.org/article/58394ec5c3864834a0dd0ad08ac8bc59
Autor:
B. A. Akbalaeva, L. V. Shulzhenko, I. V. Pershukov, N. Raiimbek uulu, T. A. Batyraliev, O. V. Gurovich, V. V. Vinogradskaia, N. T. Jainakbayev, A. O. Seidalin, M. R. Kamaliyeva
Publikováno v:
Инновационная медицина Кубани, Vol 0, Iss 2, Pp 8-15 (2024)
Background: Cancer therapy-related cardiac dysfunction (CTRCD) is a new term that encompasses a wide range of potential manifestations and is etiologically associated with a wide variety of cancer treatments. Detection of early subclinical cardiac dy
Externí odkaz:
https://doaj.org/article/486c8a46f0c24822b38766fdb3ad6a00
Autor:
Hanne M. Boen, Maaike Alaerts, Inge Goovaerts, Johan B. Saenen, Constantijn Franssen, Anne Vorlat, Tom Vermeulen, Hein Heidbuchel, Lut Van Laer, Bart Loeys, Emeline M. Van Craenenbroeck
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract Background Variants in cardiomyopathy genes have been identified in patients with cancer therapy-related cardiac dysfunction (CTRCD), suggesting a genetic predisposition for the development of CTRCD. The diagnostic yield of genetic testing i
Externí odkaz:
https://doaj.org/article/d722bd93cc5b4cb3bf0e63ce250ce1f0
Autor:
Xander Jacquemyn, Junzhen Zhan, Jef Van den Eynde, Kyla Cordrey, Rita Long, Sruti Rao, Benjamin T. Barnes, W. Reid Thompson, David Danford, Shelby Kutty
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 53, Iss , Pp 101436- (2024)
Background: Anthracyclines are associated with cardiac dysfunction. Little is known about the interplay of pre-existing hypertension and treatment response. We aimed to investigate the relationship between hypertension and the development of cancer t
Externí odkaz:
https://doaj.org/article/7b5c53bf121a4a58b56979c487cfa04b